NOV 17, 2020 6:45 AM PST

6 Injections a Year Prevent HIV Infections

WRITTEN BY: Tara Fernandes

Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging results emerging from a clinical trial of an investigational drug is providing hope to these women in the form of a reliable prophylactic therapy. The injectable drug, cabotegravir, was found to be more effective than the once-a-day preventative pill Truvada (Gilead), the current gold standard for pre-exposure prophylaxis.

A group of international collaborators came together as part of the H.I.V. Prevention Trials Network to conduct the randomized, double-blind clinical trial in a cohort of over 3,000 participants across seven African countries. Their goal was to compare the efficacy of Truvada with the new drug. 

HIV affects the immune system by infecting white blood cells called CD4-positive T cells. The virus is incapable of reproducing on its own. Therefore, it relies entirely on the infected T cell to do the heavy lifting. The virus attaches to the immune cell, fusing its envelope with the cell membrane before hijacking the nucleus of the cell, forcing it to make copies of itself using the cellular machinery. More viruses are subsequently released into the blood, multiplying and weakening the body’s natural defenses over time.

The results of the trial were groundbreaking: the injection was 89 percent more effective than Truvada, compelling researchers to end the trial early. Cabotegravir is an integrase inhibitor, a type of antiretroviral that blocks the viral enzyme integrase from inserting the HIV genome into the host cell’s DNA. Besides its improved efficacy, the treatment has clear advantages over existing HIV prophylactics: individuals only need to get a shot once every couple of months and the drug does not require refrigeration, allowing mobile clinics to administer it to women together with injectable birth controls.

One drawback is that there is a higher risk of viral resistance in the event that the injection schedule is disrupted. “If you go too long, and you get exposed to H.I.V., you could get a drug-resistant virus, so every eight weeks is going to be mandatory,” said Dr. Monica Gandhi, an H.I.V. expert at the University of California, San Francisco. “And because of that, to keep adherence to that type of schedule, we have to be creative.”

 

 

Sources: New York Times, World Health Organization.


 

About the Author
PhD
Interested in health technology and innovation.
You May Also Like
SEP 01, 2022
Cancer
Pre-clinical Study Describes a Strategy to Improve Adoptive Cell Therapy
SEP 01, 2022
Pre-clinical Study Describes a Strategy to Improve Adoptive Cell Therapy
Immune cells, known as T cells (also called T lymphocytes), play a vital role in the anti-tumor immune response.  T ...
SEP 04, 2022
Drug Discovery & Development
Brief Exposure to Cancer Drug Produces Anti-aging Effects in Mice
SEP 04, 2022
Brief Exposure to Cancer Drug Produces Anti-aging Effects in Mice
Brief exposure to rapamycin, a promising anti-aging drug, may have similar effects on health and lifespan as longer trea ...
SEP 29, 2022
Neuroscience
How the Circadian Clock Promotes Injury Recovery
SEP 29, 2022
How the Circadian Clock Promotes Injury Recovery
A new study conducted by a research team at Children's National Hospital examined how the body’s internal cloc ...
OCT 10, 2022
Microbiology
Ticks Can Weaken the Immune Response in Human Skin
OCT 10, 2022
Ticks Can Weaken the Immune Response in Human Skin
Lyme disease occurs when a blacklegged tick that is infected with Borrelia burgdorferi bacteria bites a human, and the i ...
OCT 09, 2022
Immunology
A Gel Treatment for Gum Disease is in Development
OCT 09, 2022
A Gel Treatment for Gum Disease is in Development
Scientists have developed a gel that can relieve multiple symptoms of gum disease, and brings better health to the oral ...
NOV 18, 2022
Cell & Molecular Biology
Mitochondria Can Signal to the Immune & Nervous Systems
NOV 18, 2022
Mitochondria Can Signal to the Immune & Nervous Systems
Mitochondria are little organelles that have long been known as the powerhouses of the cell. But in recent years, scient ...
Loading Comments...